Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaike Chemical Group Regulatory News (HAIK)

  • There is currently no data for HAIK

Re Joint Venture

20 Apr 2009 09:13

RNS Number : 8139Q
HaiKe Chemical Group Ltd.
20 April 2009
 



 

HaiKe Chemical Group Ltd announces Joint Venture with Xindu Group and Jindayuan

HaiKe Chemical Group Ltd ("HaiKe" or the "Company") the AIM quoted (AIM : HAIK) petrochemical and speciality chemical business based in China is pleased to announce that it has entered into a joint venture with Xindu Group Company Ltd., an investment company focused on the oil and gas sector, and Jindayuan Real Estate Company Ltd., an oil and gas infrastructure developer. HaiKe's principal goal from the joint venture is to increase the production and sale of its petrochemical products. 

HaiKe has taken a 49% stake in the new joint venture company, Dongying Hi-Tech Ruilin Chemical Co., Ltd (the "Joint Venture" or "Ruilin"), and the remaining 51% is held between the two joint venture partners, both of which are well established regional companies. The value of the initial investment into the joint venture will be RMB 400 million of which HaiKe will provide RMB 196 million, funded entirely by cash.  The Joint Venture has not yet commenced trading. 

The board of Ruilin comprises five members of which three directors are designated by HaiKe and the other two by each of the joint venture partners. 

The Joint Venture is part of the Chinese Central Government's plan to vertically integrate petrochemical businesses to encourage further growth and efficiency in the sector. Ruilin will produce and sell gasoline, diesel oil, liquefied gas, asphalt and heavy oil domestically, where demand currently outweighs supply. Located three miles from Dongying Port, an important economic hub, the Joint Venture has easy access to cheap and  efficient transportation for its feedstock and finished products. 

Mr. Yang Xiaohong, Executive Chairman, said: 

"The establishment of this joint venture is an exciting opportunity for HaiKe to grow its petrochemical business and take advantage of the demand for our products in China. Xindu and Jindayuan have excellent reputations, extensive expertise and are ideal partners for us to accelerate our expansion plans and provide us with a strong foundation for further growth."

HaiKe

Nick Su, Chief Financial Officer

+86 (546) 8289 173

+86 137 8060 5789

Hanson Westhouse

Tim Metcalfe / Christine Zhang / Martin Davison 

+44 (0) 20 7601 6100

Cardew Group

Rupert Pittman / Shan Willenbrock / Catherine Maitland 

+44 (0) 20 7930 0777

 

Notes to Editors

HaiKe Chemical Group

HaiKe Chemical Group Ltd is a petrochemical, speciality chemical and biochemical business based in Shandong province, China. The Group's principal products are diesel and other oil-related products produced through oil refining operations, as well as speciality chemical and biochemical products. The Company currently has an annual oil refining capacity of 1.8 million tons and a speciality chemicals and bio-chemicals production capacity of 545 thousand tons. HaiKe was admitted to AIM, a market operated by the London Stock Exchange on 14 February 2007. At the time, the Company successfully raised US$17 million (after expenses) to facilitate its growth.

Xindu Group

Xindu Group is a holding company focused on financial investments of oil and gas related activities in China. The Group specialises in the investment of petroleum technological development, petroleum and gas engineering and urban gas pipelines.

Jindayuan

Jindayuan is a China based infrastructure developer specialising in infrastructure construction of urban gas and natural gas pipelines and facilities management

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
JVEGIGDSBBDGGCG
Date   Source Headline
19th Mar 20182:38 pmRNSExit Facility and Cancellation
12th Mar 20188:07 amRNSResult of EGM
16th Feb 20187:00 amRNSProposed Cancellation, EGM and Exit Facility
16th Jan 201810:00 amRNSTrading Update
21st Sep 20173:16 pmRNSHolding(s) in Company
1st Sep 20177:00 amRNSHalf-year Report
26th Jun 20177:00 amRNSResult of AGM and Company Update
2nd Jun 20175:11 pmRNSAnnual Financial Report
1st Jun 20177:12 amRNSFinal Results
26th May 201710:43 amRNSBoard Appointment
23rd Jan 20178:00 amRNSTrading Statement
27th Sep 20167:36 amRNSHalf-year Report
6th Sep 20167:09 amRNSTrading Update - Correction
20th Jul 20167:00 amRNSDirectorate Change
27th Jun 201611:38 amRNSResult of AGM
3rd Jun 201611:59 amRNSAnnual Financial Report
31st May 20167:00 amRNSFinal Results
11th May 20169:01 amRNSNotice of Results and Update
8th Jan 201610:38 amRNSTrading Statement
6th Jan 20167:00 amRNSChange of name of Nominated Adviser and Broker
25th Sep 20157:00 amRNSHalf Yearly Report
14th Sep 20157:00 amRNSTrading Statement
8th Jun 20157:00 amRNSResult of AGM
14th May 201512:38 pmRNSAnnual Financial Report and Notice of AGM
1st May 20157:00 amRNSFinal Results
23rd Jan 20157:00 amRNSTrading Statement
30th Sep 20148:02 amRNSHalf Yearly Report
21st Jul 20147:00 amRNSResult of AGM
30th Jun 201410:15 amRNSPosting of Annual Report and Accounts
25th Jun 20147:00 amRNSFinal Results
15th May 20148:23 amRNSResult of General Meeting
29th Apr 201411:59 amRNSProposed Restructuring of the Group
13th Dec 20138:55 amRNSTrading Statement
20th Sep 20137:00 amRNSHalf Yearly Report
22nd Jul 20137:00 amRNSTrading Statement
8th Jul 201310:02 amRNSResult of AGM
12th Jun 20139:04 amRNSNotice of AGM and Posting of Annual Report
20th May 20137:00 amRNSFinal Results
29th Apr 20139:30 amRNSDirectorate Change
15th Feb 201310:56 amRNSDirectorate Change
25th Jan 20137:00 amRNSTrading Update
21st Jan 201310:18 amRNSDirectorate Change
1st Oct 20127:00 amRNSDirectorate Change
7th Sep 201210:51 amRNSHalf Yearly Report
31st Jul 20128:36 amRNSTrading Statement
17th Jul 20127:13 amRNSDividend Payment
17th Jul 20127:10 amRNSBuyout of key refinery subsidiary
19th Jun 20127:00 amRNSResult of AGM and Trading Update
29th May 20122:18 pmRNSDirector/PDMR Shareholding
28th May 201212:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.